Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/NOV stock hub

FRA/NOV has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/NOVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

172.2B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/NOV

In the news

Latest news · FRA/NOV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.2

P25 n/aP50 n/aP75 n/a

Trailing P/E10.6

P25 n/aP50 n/aP75 n/a

ROE71.4

P25 n/aP50 n/aP75 n/a

ROIC40.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/NOV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

234

Groups with data

Currency

DKK

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Denmark
Country code	DE
Employees	67,900
Employees Change	-7,844%
Employees Change Percent	-10.14
Enterprise value	EUR 188.9B
Exchange	Frankfurt Stock Exchange
Financial currency	DKK
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 172.2B
Price	EUR 39.14
Price currency	EUR
Rev Per Employee	645,933.94x
Sic	2834
Symbol	fra/NOV
Website	https://www.novonordisk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.47%
EV Earnings	11.58x
EV/EBIT	8.74x
EV/EBITDA	8.04x
EV/FCF	23.37x
EV/Sales	4.31x
FCF yield	4.69%
Forward P/E	14.16x
P/B ratio	6.34x
P/E ratio	10.56x
P/S ratio	3.93x
PE Ratio10 Y	25.85x
PE Ratio3 Y	28.73x
PE Ratio5 Y	30.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	49.25%
EBITDA Margin	53.04%
FCF margin	18.43%
Gross margin	83.2%
Gross Profit	EUR 36.5B
Gross Profit Growth	6.28%
Gross Profit Growth Q	27.65%
Gross Profit Growth3 Y	19.81%
Gross Profit Growth5 Y	20.91%
Net Income	EUR 16.3B
Net Income Growth	16.58%
Net Income Growth Q	67.24%
Net Income Growth3 Y	25.89%
Net Income Growth5 Y	23.26%
Pretax Margin	47.49%
Profit Margin	37.2%
Profit Per Employee	EUR 240,318
ROA	19.25
Roa5y	21.35
ROCE	48.33
ROE	71.4
Roe5y	74.56
ROIC	40.42
Roic5y	68.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.73%
Cagr15y	12.94%
Cagr1y	-31.7%
Cagr20y	17.43%
Cagr3y	-16.99%
Cagr5y	6.85%
Div CAGR10	13.82%
Div CAGR3	23.45%
Div CAGR5	20.7%
EPS Growth	16.75
EPS Growth Q	67.08
EPS Growth3 Y	26.65
EPS Growth5 Y	24.4
FCF Growth	-23.77%
FCF Growth Q	12.96%
FCF Growth3 Y	-4.69%
FCF Growth5 Y	4.87%
OCF Growth	-9.84%
OCF Growth Q	-2.61%
OCF Growth10 Y	11.02%
OCF Growth3 Y	11.65%
OCF Growth5 Y	17.37%
Revenue Growth	8.13x
Revenue Growth Q	23.99x
Revenue Growth3 Y	20.3x
Revenue Growth5 Y	20.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.63
Assets	EUR 74.8B
Cash	EUR 2.9B
Current Assets	EUR 23.7B
Current Liabilities	EUR 30.1B
Debt	EUR 19.6B
Debt EBITDA	EUR 0.83
Debt Equity	EUR 0.72
Debt FCF	EUR 2.42
Equity	EUR 27.2B
Interest Coverage	38.38
Liabilities	EUR 47.7B
Long Term Assets	EUR 51.1B
Long Term Liabilities	EUR 17.5B
Net Cash	EUR -16.7B
Net Cash By Market Cap	EUR -9.69
Net Debt EBITDA	EUR 0.72
Net Debt Equity	EUR 0.61
Net Debt FCF	EUR 2.06
Tangible Book Value	EUR 9.8B
Tangible Book Value Per Share	EUR 2.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.79
Inventory Turnover	1.17
Net Working Capital	EUR -5.7B
Quick ratio	0.54
Working Capital	EUR -6.4B
Working Capital Turnover	EUR -0.8

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.2%
Dividend Growth	2.52%
Dividend Growth Years	8%
Dividend per share	EUR 1.57
Dividend Years	27
Dividend Yield	4%
Ex Div Date	2026-03-27
Last Dividend	EUR 1.06
Payout Frequency	Semi-Annual
Payout Ratio	42.47%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	110.52%
1Y total return	-31.68%
200-day SMA	42.69
3Y total return	-42.81%
50-day SMA	33.52
50-day SMA vs 200-day SMA	50under200
5Y total return	39.28%
All Time High	140
All Time High Change	-72.04%
All Time High Date	2024-06-26
All Time Low	1.13
All Time Low Change	3,379.11%
All Time Low Date	2002-07-26
ATR	1.45
Ch YTD	-11.14
High	39.44
High52	71.54
High52 Date	2025-06-13
High52ch	-45.29%
Low	38.43
Low52	30.29
Low52 Date	2026-03-27
Low52ch	29.22%
Ma50ch	16.76%
Price vs 200-day SMA	-8.31%
RSI	72.06
RSI Monthly	36.47
RSI Weekly	47.24
Sharpe ratio	-0.51x
Sortino ratio	-0.55
Total Return	4.19%
Tr YTD	-8.04
Tr15y	520.35%
Tr1m	24.55%
Tr1w	3.33%
Tr3m	1.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 21.6B
Operating Income Growth	10.7
Operating Income Growth Q	53.69
Operating Income Growth3 Y	25.63
Operating Income Growth5 Y	24.88
Operating margin	49.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,179,265,266%
Net Borrowing	3,230,745,384.2
Shares Insiders	0.02%
Shares Institutions	28.04%
Shares Qo Q	-0.02%
Shares Yo Y	-0.2%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 7.9B
Average Volume	18,969.85x
Bv Per Share	6.12
CAPEX	EUR -7.8B
Ch10y	67.02
Ch15y	351.2
Ch1m	24.55
Ch1w	3.33
Ch1y	-34.74
Ch20y	1,414.1
Ch3m	-2.15
Ch3y	-47.09
Ch5y	25.25
Ch6m	-1.41
Change	-0.15%
Change From Open	0.88
Close	39.2
Days Gap	-1.02
Depreciation Amortization	1,662,515,870
Dollar Volume	354,686.7
Earnings Date	2026-05-06
EBIT	EUR 21.6B
EBITDA	EUR 23.3B
EPS	EUR 3.67
F Score	4
FCF	EUR 8.1B
FCF EV Yield	4.28x
Financing CF	-6,751,302,534
Fiscal Year End	December
Founded	1,923
Goodwill	2,658,340,274.1
Graham Number	22.6964
Graham Upside	-42.01
Income Tax	EUR 4.5B
Investing CF	-11,358,227,936
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2023-09-13
Last Split Type	Forward
Lynch Fair Value	EUR 86.25
Lynch Upside	120.4
Ma150	41.04
Ma150ch	-4.62%
Ma20	35.31
Ma20ch	10.84%
Net CF	-2,383,072,384
Next Earnings Date	2026-08-05
Open	38.8
P FCF Ratio	21.3
P OCF Ratio	10.87
Payment Date	2026-03-31
Position In Range	70.3
Ppne	29,419,215,347.3
Price Date	2026-05-08
Price EBITDA	EUR 7.4
Ptbv Ratio	17.6
Relative Volume	0.48x
Revenue	43,858,914,579x
SBC By Revenue	0.44x
Share Based Comp	191,999,824
Tax By Revenue	10.29x
Tax Rate	21.66%
Tr20y	2,384.69%
Tr6m	2.03%
Volume	9,062
Z Score	4.66

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/NOV dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.0%

$1.57 annual per share

Payout ratio

+42.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+20.7%

8 consecutive years of growth

Total shareholder yield

+4.2%

Next ex-dividend date: 2026-03-27

Performance

FRA/NOV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/NOV?

Insider, institutional, and short-interest positioning.

Institutional ownership

+28.0%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

FRA/NOV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

72.1

Above 70: short-term overbought

Price vs 200-day MA

-8.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.51

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/NOV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/NOV stock rating?

fra/NOV is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/NOV analysis?

The full report lives at /stocks/fra/NOV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/NOV?

The latest report frames fra/NOV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/NOV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.